Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1974135782', 'doi': 'https://doi.org/10.1038/sj.bjc.6602774', 'title': 'Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide', 'display_name': 'Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide', 'publication_year': 2005, 'publication_date': '2005-09-01', 'ids': {'openalex': 'https://openalex.org/W1974135782', 'doi': 'https://doi.org/10.1038/sj.bjc.6602774', 'mag': '1974135782', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/16222306', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/2361627'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/sj.bjc.6602774', 'pdf_url': 'https://www.nature.com/articles/6602774.pdf', 'source': {'id': 'https://openalex.org/S62966998', 'display_name': 'British Journal of Cancer', 'issn_l': '0007-0920', 'issn': ['0007-0920', '1532-1827'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': 'cc-by-nc-sa', 'license_id': 'https://openalex.org/licenses/cc-by-nc-sa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://www.nature.com/articles/6602774.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5060011858', 'display_name': 'J. Blake Bartlett', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I47396830', 'display_name': 'Bristol-Myers Squibb (Switzerland)', 'ror': 'https://ror.org/02xqc6638', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210091812', 'https://openalex.org/I47396830']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'J B Bartlett', 'raw_affiliation_strings': ['Celgene Corporation, 86 Morris Avenue, Summit, NJ, 07901, USA.'], 'affiliations': [{'raw_affiliation_string': 'Celgene Corporation, 86 Morris Avenue, Summit, NJ, 07901, USA.', 'institution_ids': ['https://openalex.org/I47396830']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064434327', 'display_name': 'A.W. Tozer', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I47396830', 'display_name': 'Bristol-Myers Squibb (Switzerland)', 'ror': 'https://ror.org/02xqc6638', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210091812', 'https://openalex.org/I47396830']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'A Tozer', 'raw_affiliation_strings': ['Celgene Corporation, 86 Morris Avenue, Summit, USA'], 'affiliations': [{'raw_affiliation_string': 'Celgene Corporation, 86 Morris Avenue, Summit, USA', 'institution_ids': ['https://openalex.org/I47396830']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032165288', 'display_name': 'David Stirling', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I47396830', 'display_name': 'Bristol-Myers Squibb (Switzerland)', 'ror': 'https://ror.org/02xqc6638', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210091812', 'https://openalex.org/I47396830']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'D Stirling', 'raw_affiliation_strings': ['Celgene Corporation, 86 Morris Avenue, Summit, USA'], 'affiliations': [{'raw_affiliation_string': 'Celgene Corporation, 86 Morris Avenue, Summit, USA', 'institution_ids': ['https://openalex.org/I47396830']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5055075571', 'display_name': 'Jerome B. Zeldis', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I47396830', 'display_name': 'Bristol-Myers Squibb (Switzerland)', 'ror': 'https://ror.org/02xqc6638', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210091812', 'https://openalex.org/I47396830']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'J B Zeldis', 'raw_affiliation_strings': ['Celgene Corporation, 86 Morris Avenue, Summit, USA'], 'affiliations': [{'raw_affiliation_string': 'Celgene Corporation, 86 Morris Avenue, Summit, USA', 'institution_ids': ['https://openalex.org/I47396830']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3790, 'currency': 'EUR', 'value_usd': 4690, 'provenance': 'doaj'}, 'apc_paid': {'value': 3790, 'currency': 'EUR', 'value_usd': 4690, 'provenance': 'doaj'}, 'fwci': 1.698, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 63, 'citation_normalized_percentile': {'value': 0.602151, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 94, 'max': 95}, 'biblio': {'volume': '93', 'issue': '6', 'first_page': '613', 'last_page': '619'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10649', 'display_name': 'Diagnosis and Treatment of Multiple Myeloma', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10649', 'display_name': 'Diagnosis and Treatment of Multiple Myeloma', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Targeted Protein Degradation in Biomedical Research', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11752', 'display_name': 'Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment', 'score': 0.9979, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/immunomodulatory-drugs', 'display_name': 'Immunomodulatory Drugs', 'score': 0.474784}], 'concepts': [{'id': 'https://openalex.org/C2779609412', 'wikidata': 'https://www.wikidata.org/wiki/Q203174', 'display_name': 'Thalidomide', 'level': 3, 'score': 0.9798709}, {'id': 'https://openalex.org/C2776063141', 'wikidata': 'https://www.wikidata.org/wiki/Q425681', 'display_name': 'Lenalidomide', 'level': 3, 'score': 0.9759231}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.8237184}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.65249336}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.52461445}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.4282514}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.36850268}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.32768977}], 'mesh': [{'descriptor_ui': 'D007166', 'descriptor_name': 'Immunosuppressive Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D009190', 'descriptor_name': 'Myelodysplastic Syndromes', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D013792', 'descriptor_name': 'Thalidomide', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007166', 'descriptor_name': 'Immunosuppressive Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077269', 'descriptor_name': 'Lenalidomide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009190', 'descriptor_name': 'Myelodysplastic Syndromes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009190', 'descriptor_name': 'Myelodysplastic Syndromes', 'qualifier_ui': 'Q000276', 'qualifier_name': 'immunology', 'is_major_topic': False}, {'descriptor_ui': 'D013792', 'descriptor_name': 'Thalidomide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013792', 'descriptor_name': 'Thalidomide', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/sj.bjc.6602774', 'pdf_url': 'https://www.nature.com/articles/6602774.pdf', 'source': {'id': 'https://openalex.org/S62966998', 'display_name': 'British Journal of Cancer', 'issn_l': '0007-0920', 'issn': ['0007-0920', '1532-1827'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': 'cc-by-nc-sa', 'license_id': 'https://openalex.org/licenses/cc-by-nc-sa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc2361627', 'pdf_url': 'https://europepmc.org/articles/pmc2361627?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361627', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/16222306', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/sj.bjc.6602774', 'pdf_url': 'https://www.nature.com/articles/6602774.pdf', 'source': {'id': 'https://openalex.org/S62966998', 'display_name': 'British Journal of Cancer', 'issn_l': '0007-0920', 'issn': ['0007-0920', '1532-1827'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': 'cc-by-nc-sa', 'license_id': 'https://openalex.org/licenses/cc-by-nc-sa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.7, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 42, 'referenced_works': ['https://openalex.org/W1597238753', 'https://openalex.org/W1942265032', 'https://openalex.org/W1970309861', 'https://openalex.org/W1970510435', 'https://openalex.org/W1996131208', 'https://openalex.org/W2026742920', 'https://openalex.org/W2032411201', 'https://openalex.org/W2033556677', 'https://openalex.org/W2048507165', 'https://openalex.org/W2059873406', 'https://openalex.org/W2078945448', 'https://openalex.org/W2104238785', 'https://openalex.org/W2107710197', 'https://openalex.org/W2113101033', 'https://openalex.org/W2117327010', 'https://openalex.org/W2117768107', 'https://openalex.org/W2118006412', 'https://openalex.org/W2119810076', 'https://openalex.org/W2120161314', 'https://openalex.org/W2125559109', 'https://openalex.org/W2127206962', 'https://openalex.org/W2133986577', 'https://openalex.org/W2144531125', 'https://openalex.org/W2148188974', 'https://openalex.org/W2151150609', 'https://openalex.org/W2153140330', 'https://openalex.org/W2168929741', 'https://openalex.org/W2171194005', 'https://openalex.org/W2209204325', 'https://openalex.org/W2241988922', 'https://openalex.org/W2268739714', 'https://openalex.org/W2548272071', 'https://openalex.org/W2556425716', 'https://openalex.org/W2559630434', 'https://openalex.org/W2560218271', 'https://openalex.org/W2567309278', 'https://openalex.org/W2589358522', 'https://openalex.org/W2589566794', 'https://openalex.org/W2590648458', 'https://openalex.org/W2594463071', 'https://openalex.org/W2979878259', 'https://openalex.org/W2980228094'], 'related_works': ['https://openalex.org/W3047575701', 'https://openalex.org/W3042537788', 'https://openalex.org/W2979889274', 'https://openalex.org/W2462844398', 'https://openalex.org/W2118112957', 'https://openalex.org/W2058009067', 'https://openalex.org/W2041042375', 'https://openalex.org/W2022036807', 'https://openalex.org/W1980068016', 'https://openalex.org/W1974135782'], 'abstract_inverted_index': {'Thalidomide': [0], 'is': [1, 16], 'effective': [2], 'in': [3, 18, 40], 'the': [4, 31], 'treatment': [5], 'of': [6, 33], 'multiple': [7, 26], 'myeloma.': [8, 27], 'The': [9], 'immunomodulatory': [10], 'drug': [11], 'and': [12, 25, 35], 'thalidomide': [13, 46], 'analogue': [14], 'lenalidomide': [15, 37], 'currently': [17], 'late': [19], 'stage': [20], 'clinical': [21, 38], 'development': [22, 39], 'for': [23], 'MDS': [24], 'This': [28], 'minireview': [29], 'highlights': [30], 'course': [32], 'initial': [34], 'ongoing': [36], 'oncology': [41], 'with': [42], 'reference': [43], 'to': [44], 'earlier': [45], 'studies.': [47]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1974135782', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 2}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 4}, {'year': 2012, 'cited_by_count': 6}], 'updated_date': '2024-08-31T14:55:19.634131', 'created_date': '2016-06-24'}